Safety concerns remain because unapproved BPC-157 products can vary in purity, strength, and sterility
Gyires K, Toth VE, Zadori ZS
Easy measuring: At ~3.33 mg/mL, 1 unit 33 mcg on a U-100 syringe
In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list
Without clinical data, it is challenging to ascertain the potential short-term or long-term adverse effects of BPC-157
B12 FACTS: B12 injections are typically used as a treatment for a certain type of anemia (pernicious anemia)